Irbesartan inhibits metastasis by interrupting the adherence of tumor cell to endothelial cell induced by angiotensin II in hepatocellular carcinoma

BACKGROUND: The use of angiotensin II inhibitors is associated with a low risk of recurrence and metastasis in hepatocellular carcinoma (HCC) patients. Vascular cell adhesion molecule-1 (VCAM-1) is a key factor in tumor metastasis. METHODS: The effects of angiotensin II and irbesartan (an angiotensi...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Long-Hai, Sun, Hui-Chuan, Zhu, Xiao-Dong, Zhang, Shi-Zhe, Li, Xiao-Long, Li, Kang-Shuai, Liu, Xue-Feng, Lei, Ming, Li, Yan, Tang, Zhao-You
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940954/
https://www.ncbi.nlm.nih.gov/pubmed/33708834
http://dx.doi.org/10.21037/atm-20-5293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940954/
https://www.ncbi.nlm.nih.gov/pubmed/33708834
http://dx.doi.org/10.21037/atm-20-5293

Ejemplares similares